No More Finger Pricks? This Tiny Microneedle Patch Could Track Blood Sugar Without Painful Blood Tests
For millions of people living with diabetes, monitoring blood glucose is an essential part of daily life. Keeping track of changing glucose levels helps patients and doctors identify dangerous fluctuations early and take action before complications develop. However, traditional glucose monitoring can be uncomfortable and inconvenient.
A new wearable technology developed by researchers at The Hong Kong Polytechnic University (PolyU) could offer a different approach. Scientists have created an enzyme-free microneedle patch called ARMPatch that can continuously monitor changes in blood glucose using a standard ultrasound probe.
The technology could eventually make glucose monitoring less painful, more convenient and potentially longer-lasting than many existing systems.
The Problem With Traditional Glucose Monitoring
Conventional blood glucose testing usually requires a small blood sample, often obtained by pricking the fingertip. Although the procedure is simple, repeated testing can become painful and inconvenient, especially for people who need to monitor their glucose levels frequently.
Continuous glucose monitoring (CGM) systems have reduced the need for repeated finger-prick tests. However, many existing CGM technologies depend on biological enzymes to detect glucose.
These enzyme-based systems can have several limitations. Their sensors need to be replaced regularly, which can increase long-term costs. Enzymes can also require careful storage and handling because their performance may be affected by environmental conditions.
The PolyU research team wanted to explore another possibility: Can glucose be detected without using enzymes?
Their answer is the ARMPatch.
How Does the ARMPatch Work?
The basic idea behind the technology is surprisingly simple.
The ARMPatch contains tiny microneedles made using a glucose-responsive hydrogel based on a material called phenylboronic acid (PBA).
When the patch is placed on the skin, its microscopic needles interact with the body's fluid beneath the skin. When glucose levels change, the hydrogel responds by changing its volume.
In simple terms, higher glucose levels cause the microneedles to swell more.
Instead of using an electrical signal or an enzyme-based chemical reaction to measure this change, researchers use ultrasound.
An ultrasound probe sends sound waves toward the patch. The ultrasound signal can detect changes in the size of the microneedles. By measuring how much the microneedles have swollen, the system can determine changes in glucose concentration.
This is why the researchers describe the technology as "acoustically readable."
The patch essentially converts a chemical change—glucose concentration—into a physical change that ultrasound can detect.
Promising Long-Term Performance
Researchers tested the ARMPatch through both laboratory and animal experiments.
During laboratory testing, the technology demonstrated a strong and linear response across a glucose concentration range of 0–40 mM. This range is broad enough to cover glucose levels associated with hyperglycemia.
One of the most interesting findings was the patch's durability.
The researchers reported that the device provided stable readings for up to 56 days in laboratory testing. This could be an important advantage over many enzyme-based sensors that require more frequent replacement.
A longer-lasting sensor could potentially reduce waste, lower monitoring costs and make continuous monitoring more convenient.
However, it is important to note that the 56-day performance was demonstrated in laboratory experiments. It does not yet mean that people with diabetes can use the patch for 56 days in everyday life.
Animal Tests Showed Encouraging Results
The researchers also tested the technology in living animals.
During experiments involving freely moving nude mice, ultrasound measurements of the microneedle swelling closely followed changes in blood glucose levels.
Most importantly, the patch remained attached to the animals' skin for seven consecutive days, even while they were moving freely.
After the patch was removed, researchers observed no inflammation or scarring at the application site. This provided encouraging evidence about the patch's biocompatibility and minimally invasive design.
These results suggest that the microneedle system can remain stable on the skin while collecting useful glucose-related information.
Still, animal testing is an early stage of development. Human clinical studies will be necessary to determine how accurately and safely the technology performs in people with diabetes.
A Major Advantage: Using Existing Ultrasound Technology
One of the most interesting features of ARMPatch is that it does not necessarily require a completely new monitoring system.
The researchers designed it to work with a standard ultrasound probe.
This could be particularly useful as portable ultrasound technology becomes more accessible. People who already use portable ultrasound devices for long-term monitoring of health conditions could potentially use the same equipment with the ARMPatch.
Instead of developing a completely separate glucose-monitoring device, researchers are exploring whether existing ultrasound technology can become a platform for monitoring multiple health indicators.
This could make the technology more versatile and potentially reduce the need for additional hardware.
Beyond Blood Glucose
The potential applications of the technology may extend far beyond diabetes.
According to the research team, the hydrogel chemistry can potentially be modified to respond to different biological substances.
With appropriate changes to the hydrogel composition, similar microneedle patches could potentially be designed to monitor biomarkers such as pH, proteins and bacteria.
This raises the possibility of creating a single wearable ultrasound-based platform capable of monitoring several physiological signals.
In the future, researchers hope to develop multi-biomarker microneedle patches that could simultaneously track different indicators of a person's health.
Such a system could turn portable ultrasound devices into a kind of one-stop health monitoring platform.
What Makes This Technology Different?
The ARMPatch combines several technologies that are usually considered separately: microneedles, responsive hydrogels and ultrasound imaging.
The microneedles provide minimally invasive access to information beneath the skin. The hydrogel responds to glucose. Ultrasound then reads the resulting physical change without requiring a traditional blood sample.
The absence of biological enzymes is another important feature.
By avoiding enzymes, researchers aim to create a sensing platform that could be more stable and potentially last longer than conventional enzyme-based approaches.
However, several challenges remain before the technology can become a practical diabetes-monitoring product. Researchers will need to establish its accuracy, reliability, safety and comfort in human trials. They will also need to determine how well the patch performs during exercise, sweating, temperature changes and other everyday conditions.
A New Direction for Wearable Healthcare
The ARMPatch research represents an interesting shift in the way wearable biosensors could work.
Instead of measuring a biomarker through a conventional electrical or enzyme-based sensor, the system uses a physical response that can be observed through sound waves.
The research was led by Prof. Su Zhongqing, head of the Department of Mechanical Engineering and chair professor of Intelligent Structures and Systems at PolyU, along with Prof. Meng Long of the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences and Prof. Jae-Woong Jeong of the Korea Advanced Institute of Science and Technology. The study was published in Science Advances, with PolyU doctoral student Zhang Wanglinhan serving as the first author.
Prof. Su described the ARMPatch as a blood glucose monitoring accessory designed to work with regular ultrasound probes, offering a potentially minimally invasive, cost-effective and long-lasting approach to enzyme-free continuous glucose monitoring.
The technology is still at the research stage, but its concept is significant. A tiny patch combined with ultrasound could one day provide a more convenient way to monitor glucose and other important biological signals.
For people managing diabetes, the ultimate goal is simple: less pain, fewer replacements and easier access to continuous health information.
If further research and human trials confirm its performance, technologies such as ARMPatch could help move wearable healthcare toward a future where one small patch and one ultrasound device can monitor multiple aspects of human health.
Reference: Wanglinhan Zhang et al, Augmenting ultrasound for continuous glucose monitoring via a wearable acoustically readable microneedle patch, Science Advances (2026). DOI: 10.1126/sciadv.aec3209

Comments
Post a Comment